The Endonucleases market is benefiting from advances in gene therapy research. Specialized nucleases support the development and investigation of gene-editing approaches for potential treatment of inherited and acquired disorders. The endonucleases market size is expected to reach US$ 892.51 million by 2034 from US$ 395.07 million in 2025, registering a CAGR of 9.48% during 2026–2034....